Search

Your search keyword '"Kunze-Schumacher, Heike"' showing total 40 results

Search Constraints

Start Over You searched for: Author "Kunze-Schumacher, Heike" Remove constraint Author: "Kunze-Schumacher, Heike"
40 results on '"Kunze-Schumacher, Heike"'

Search Results

5. High-resolution mapping of cell-cycle dynamics during steady-state T-cell development and regeneration in vivo

8. Molecular and cellular control of intrathymic T-cell development

9. Guidelines for the use of flow cytometry and cell sorting in immunological studies (third edition)

10. Modeling the dynamics of T-cell development in the thymus

11. High-resolution mapping of cell cycle dynamics during steady-state T cell development and regeneration in vivo

12. The Role of MicroRNAs in Development and Function of Regulatory T Cells – Lessons for a Better Understanding of MicroRNA Biology

13. Guidelines for the use of flow cytometry and cell sorting in immunological studies (third edition)

16. Guidelines for the use of flow cytometry and cell sorting in immunological studies (second edition)

17. Releasing the concept of HLA‐allele specific peptide anchors in viral infections: A non‐canonical naturally presented human cytomegalovirus‐derivedHLA‐A*24:02restricted peptide drives exquisite immunogenicity

18. miR-181a/b-1 controls thymic selection of Treg cells and tunes their suppressive capacity

19. Guidelines for the use of flow cytometry and cell sorting in immunological studies (second edition)

20. miR-181a/b-1 controls thymic selection of Treg cells and tunes their suppressive capacity

24. miR‐191 modulates B‐cell development and targets transcription factors E2A, Foxp1, and Egr1

26. Germline deletion reveals a non-essential role of the atypical MAPK6/ERK3

27. miRNA miR-21 is largely dispensable for intrathymic T-cell development

28. Releasing the concept of HLA‐allele specific peptide anchors in viral infections: A non‐canonical naturally presented human cytomegalovirus‐derived HLA‐A*24:02 restricted peptide drives exquisite immunogenicity.

29. MicroRNA miR‐181a/b‐1 controls MAIT cell development.

32. Soluble HLA Technology as a Strategy to Evaluate the Impact of HLA Mismatches

33. miR‐191 modulates B‐cell development and targets transcription factors E2A, Foxp1, and Egr1.

35. OR25

36. OR20

Catalog

Books, media, physical & digital resources